ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/000/SRR3929610/SRR3929610.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/006/SRR3929606/SRR3929606.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/004/SRR3929604/SRR3929604.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/008/SRR3929608/SRR3929608.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/006/SRR3929616/SRR3929616.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/000/SRR3929600/SRR3929600.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/002/SRR3929602/SRR3929602.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/003/SRR3929613/SRR3929613.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/005/SRR3929605/SRR3929605.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/007/SRR3929607/SRR3929607.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/001/SRR3929611/SRR3929611.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/008/SRR3929618/SRR3929618.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/003/SRR3929603/SRR3929603.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/009/SRR3929599/SRR3929599.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/005/SRR3929615/SRR3929615.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/004/SRR3929614/SRR3929614.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/007/SRR3929617/SRR3929617.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/002/SRR3929612/SRR3929612.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/009/SRR3929609/SRR3929609.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR392/001/SRR3929601/SRR3929601.fastq.gzprimaryOK200GenomicsUniveristy of California San Diegohttps://www.ebi.ac.uk/ena/browser/view/PRJNA329549Mus musculusPurpose: The goals of this study were to identify quantitative gene expression differences between whole tumor and tumor-associated macrophages (TAMs) derived from Lewis lung carcinoma (LLC) tumors grown in wild type and PI3Kinase-gamma-null mice. Methods: mRNA profiles of whole tumor or tumor-associated macrophages (CD11b+Gr1- cells) from wild type (WT) or PI3Kinase-gamma-knockout (p110g-/-) mice were generated by single deep read sequencing, in triplicate or quadruplicate, using Illumina HiSeq 2000. The sequence reads that passed quality filters were aligned to mouse transcriptome using the bowtie2 aligner. Gene-level summaries were normalized and analyzed for differential expression using DESeq. Overall design: mRNA profiles of whole tumor and tumor-associated macrophages from WT and p110g-/- mice were generated by deep sequencing in triplicate or quadruplicate using Illumina HiSeq 2000.xref:PubMed:27642729ENA5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma, Malignant Neoplasm, determination, Monocyte Derived Macrophages, 2.7.1.153, Neoplasms, number, Benign Neoplasm, A4, PI3K, Phosphoinositide-3-kinase catalytic gamma polypeptide, PtdIns-3-kinase subunit p110-gamma, Monocyte Derived, Tumor, PtdIns-3-kinase subunit gamma, Malignant, presence, TYPE, LGMD2C, DAGA4, count in organism, PIK3, 2.7.11.1, Monocyte-Derived, Phosphatidylinositol 4, Benign, chemical analysis, Neoplasm, PI3CG, MAM, SCG3, Monocyte-Derived Macrophages, Macrophage, DMDA1, Malignancy, Macrophages, Benign Neoplasms, Bone Marrow Derived Macrophages, Bone Marrow-Derived Macrophage, Cancers, p110gamma, PI3Kgamma, Malignant Neoplasms, PI3-kinase subunit gamma, Neoplasias, Bone Marrow-Derived, Monocyte-Derived Macrophage., 5830428L06Rik, PI3K-gamma, DMDA, SCARMD2, Bone Marrow-Derived Macrophages, Malignancies, assay, p120-PI3K, associated, other neoplasm, Serine|threonine protein kinase PIK3CG, Neoplasia, Cancer, TumorsMus musculus, Laboratory Mice., House, Mus, Laboratory, Swiss, Mus domesticus, mouse, Mus musculus domesticus, Swiss Mouse, mouse <Mus musculus>, Mouse, House Mice, Swiss Mice, house mouse, Mice, Laboratory Mouse, House Mouse, mice C57BL/6xCBA/CaJ hybrid, domesticus, Mus muscarisfalseMus musculusNext-generation sequencing and quantitative analysis of wild type and p110gamma -/- tumors and tumor-associated macrophages2025-09-242016-09-02PRJNA329549GSE845351009027642729